CONSISTENT SALES GROWTH
FY18 gross sales tripled to $18.42M with 330% net
revenue growth YOY.
This momentum continued into Q1 FY19, with quarterly
sales revenue up 416% on same period last year to
$8.98M. Bubs infant formula sales grew 99% pcp.
OUTLOOK
We expect to exceed 2018 full-year revenue performance
by half-year 2019.
This positive growth momentum is expected to further
accelerate in the second half of FY19, with a significant
portion of planned incremental sales to China via B2C
CBEC, C2C Corporate Daigou and MBS channels, as well as
new product launches in 2H FY19.
Ann: 2018 AGM - CEO Presentation, page-3
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BUB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $120.4M | |||
| Open | High | Low | Value | Volume |
| 13.5¢ | 13.5¢ | 13.0¢ | $142.8K | 1.076M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 45 | 2683573 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 518483 | 8 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| BUB (ASX) Chart |